EUVIMED · CrossrefJournal
Medicine in Drug Discovery
ISSN 2590-0986 · Elsevier BV
Latest articles
From mushroom metabolome to prioritized anti-diabetic metabolite candidates: LC-MS/MS and AIDDISON™-assisted screening of Pleurotus citrinopileatus
GPCR-PTM: an interpretable, topology-aware rule-based framework for residue-level post-translational modification annotation and prediction across the human GPCRome
5-O-(3-Indolecarbonyl) Renieramycin T suppresses c-Myc and cancer stemness in colorectal cancer cells: insights from computational and experimental studies
Therapeutic capabilities of naturally-derived p38 MAPK inhibitors for protecting the cerebrovascular system in severe SARS‑CoV‑2 infection
Cyanobacterial peptides and polyketides: biosynthetic basis, structural diversity and therapeutic relevance
Harnessing QSAR and machine learning for the design of hepatocellular carcinoma inhibitors; experimental validation of the cytotoxicity of new compounds against HepG2 cells
Rhinacanthins from Rhinacanthus nasutus inhibit the Plasmodium falciparum mitochondrial cytochrome bc1 complex revealed by chemical genetic and in silico studies
Duration of tenofovir disoproxil fumarate treatment and a rapid eGFR decline in a retrospective cohort of people living with HIV infection
Natural products triggering non-apoptotic regulated cell death in lung cancer: A systematic review focusing on pyroptosis, with insights into cuproptosis and necroptosis
Phenanthrene and dihydrophenanthrene derivatives from Vanda curvifolia with cytotoxic activity against glioblastoma cells
A monoterpenoid dihydrochalcone derivative isolated from Conamomum rubidum sensitizes erlotinib-mediated lung cancer cell death by suppressing STAT3/Bcl-2 signaling
Dendrophenol Mitigates Inflammatory Sickness Behaviors and Maintains CNS Function in Murine Models
Psychedelics; an untapped therapeutic niche: a narrative review in the future of cancer pain management
3D printing in drug delivery: emerging technologies, clinical translation, and the future of personalized medicine
Microbiota-derived metabolites in cancer: Dual roles in pathogenesis and opportunities for therapy
From ferments to fixers: Postbiotics in wound healing
Revolutionizing pharmacology: AI-powered approaches in molecular modeling and ADMET prediction
A bispecific ADC against CCR8 and TNFR2 elicits potent antitumor efficacy
Combating bacterial antibiotic resistance with phytocompounds: Current trends and future perspectives
NeBULA: a web-based novel drug design platform for up-to-date bioisosteric replacement
Molecular strategies in BRAF targeting: advances in patents, structure activity relationship and future prospects
Repurposing oncology drugs for Alzheimer’s: multi-omic convergence targeting cell-cycle, proteostasis, immunometabolism, and senescence
Antioxidant and biocompatible CuO-starch/PVA nanoscaffolds via ultrasonic green synthesis using Turbinaria conoides (brown marine macroalgae)
Novel indole-based synthetic molecules in cancer treatment: Synthetic strategies and structure-activity relationship
Current demands for standardization of Indian medicinal plants: A critical review
Generative AI for drug discovery and protein design: the next frontier in AI-driven molecular science
Repositioning of rhodanine-thiazole hybrids as aldose reductase inhibitors
Leveraging network pharmacology for drug discovery: Integrative approaches and emerging insights
Design and development of PROTACs: A new paradigm in anticancer drug discovery
Bacterial-based drug delivery systems: A new way to combat infectious disease
EUVIMED